Abstract
Background
Oophorectomy is generally performed in patients with endometrial cancer despite the rate of ovarian metastasis being relatively low.
Patients and methods
A multicenter retrospective registry-based study was performed in 2329 patients with endometrial cancer. The outcome measures were the incidence of ovarian metastasis and the impact on overall survival.
Results
Median follow-up was performed at 84 months. A total of 2158 women were eligible for analysis, of which 131 (6.1%) had ovarian metastasis. Women with ovarian metastasis were more likely to have > 50% myometrial invasion, undifferentiated nonendometrioid tumors, and lymph and vascular space invasion. The presence of < 50% myometrial invasion, endometrioid histology, well-differentiated cancer, and negative lymph and vascular space invasion were associated with a very low rate (0.5%) of ovarian metastasis. Notably, after matching for tumor histology and grade, myometrial invasion, and lymph and vascular space invasion, ovarian metastasis was not associated with a reduced median overall survival.
Conclusions
Ovarian preservation should be offered to premenopausal women with endometrial cancer in whom myometrial invasion is less than 50%, the histological type is endometrioid and well-differentiated, and lymph and vascular space invasion is not involved.
Similar content being viewed by others
References
Dumas L, Ring A, Butler J, Kalsi T, Harari D, Banerjee S (2016) Improving outcomes for older women with gynaecological malignancies. Cancer Treat Rev 50:99–108
Eggemann H, Ignatov T, Kaiser K, Burger E, Costa SD, Ignatov A (2016) Survival advantage of lymphadenectomy in endometrial cancer. J Cancer Res Clin Oncol 142(5):1051–1060
Eggemann H, Ignatov T, Burger E, Costa SD, Ignatov A (2017) Management of elderly women with endometrial cancer. Gynecol Oncol 146(3):519–524
Gemer O, Bergman M, Segal S (2004) Ovarian metastasis in women with clinical stage I endometrial carcinoma. Acta Obstet Gynecol Scand 83(2):208–210
Hetu V, Petignat P, Wu Y, Drouin P, Sauthier P, Provencher D, Gauthier P (2009) Positive adnexal or uterine serosal involvement in stage IIIC endometrial cancer is an adverse factor for recurrence. Gynecol Obstet Invest 67(3):173–177
Larson CA (2011) Evidence-based medicine: an analysis of prophylactic bilateral oophorectomy at time of hysterectomy for benign conditions. Curr Oncol 18(1):13–15
Lau HY, Twu NF, Yen MS, Tsai HW, Wang PH, Chuang CM, Wu HH, Chao KC, Chen YJ (2014) Impact of ovarian preservation in women with endometrial cancer. J Chin Med Assoc 77(7):379–384
Lee NK, Cheung MK, Shin JY, Husain A, Teng NN, Berek JS, Kapp DS, Osann K, Chan JK (2007) Prognostic factors for uterine cancer in reproductive-aged women. Obstet Gynecol 109(3):655–662
Modaress MG, Cheraghi F, Zamani N (2011) Ovarian metastasis in endometriod type endometrial cancer. Int J Fertil Steril 5(3):148–151
Pellerin GP, Finan MA (2005) Endometrial cancer in women 45 years of age or younger: a clinicopathological analysis. Am J Obstet Gynecol 193(5):1640–1644
Takeshima N, Hirai Y, Yano K, Tanaka N, Yamauchi K, Hasumi K (1998) Ovarian metastasis in endometrial carcinoma. Gynecol Oncol 70(2):183–187
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453–1457
Wright JD, Buck AM, Shah M, Burke WM, Schiff PB, Herzog TJ (2009) Safety of ovarian preservation in premenopausal women with endometrial cancer. J Clin Oncol 27(8):1214–1219
Funding
This study was not funded.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with animals performed by any of the authors. In accordance with the statement of the Research and Ethical Committee of the Otto-von-Guericke University, Magdeburg, Germany, additional individual consent for this analysis was not needed. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Written informed consent was obtained from all patients before treatment. An additional individual consent for this analysis was not needed.
Rights and permissions
About this article
Cite this article
Ignatov, T., Eggemann, H., Burger, E. et al. Ovarian metastasis in patients with endometrial cancer: risk factors and impact on survival. J Cancer Res Clin Oncol 144, 1103–1107 (2018). https://doi.org/10.1007/s00432-018-2628-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-018-2628-2